期刊文献+

158例非小细胞肺癌中3p25杂合性丢失研究 被引量:1

Allele specific chromosome 3p25 deletion detected by PCR LOH analysis in non small cell lung cancer
原文传递
导出
摘要 目的 探讨非小细胞肺癌组织 (NSCLC)中 3p2 5位点上等位基因的杂合性丢失 (LOH)与肺癌发生、发展的相关性。方法 采用银染聚合酶链反应结合二核苷酸 (CA)n重复程序出现多态性评价LOH ,分析 1 58例NSCLC癌组织中 3p2 5等位基因的LOH。结果  1 58例NSCLC组织中 80例出现 3p2 5LOH ,总的杂合性丢失率为 50 .6%。腺癌组织中 3p2 5杂合性丢失率为 62 .0 % ,鳞癌为 43 .2 % ,两者间差异有显著性 (P <0 .0 5)。 3p2 5LOH与NSCLC临床分期关系不明显 ,Ⅰ、Ⅱ及Ⅲ期分别为 52 .2 %、45.0 %及 52 .8% ,4例良性肺肿瘤和 5例正常胎儿肺组织均未出现 3p2 5LOH。结论 本研究结果表明 3p2 5LOH在NSCLC中普遍存在 ,从而说明 3p2 5位点处可能存在着某些与肺癌发生。 Objective To ascertain whether the loss of heterozygosity (LOH) of allele on chromosome 3p25 region is associated with non small cell lung cancer (NSCLC). Methods 3p25 LOH was analysed in patients with NSCLC by polymerase chain reaction based assays for dinucleatide repeat polymorphisms. Results Eighty out of 158(50.6%) cancer tissues of NSCLC were found to have 3p25 LOH, but no 3p25 LOH was observed in 5 normal fetal lung tissues and 4 tissues of the benign lung neoplasms. The deletion was detected in 62.0% of adenocarcinoma and 43.2% of the squamous carcinoma, indicating that the former was significantly higher than the latter (P<0.05) . Loss frequences for TNM stages were further observed in 52.2%, 45.0% and 52.8% of the cases for stage Ⅰ,Ⅱ and Ⅲ respectively, and these data showed no significant relationship between the loss frequence and TNM staging of NSCLC (P>0.05). Conclusion Above findings display that 3p25 LOH appear to be a common structural alteration occurred in NSCLC and there may be suppressor genes relevant to the carcinogenesis of the lung in 3p25 region.
出处 《肺癌杂志》 1998年第1期32-34,共3页
基金 上海市医学领先学科和上海市科委课题
关键词 非小细胞肺癌 3p25 杂合性丢失 PCR 肺癌 Non small cell lung cancer 3p25 Allele Loss of heterozygosity PCR-LOH analysis
  • 相关文献

参考文献11

  • 1Hibi K,Takahashi T,Yamakawa K,et al.Three distinct regions involved in 3p deletion in human lung cancer.Oncogene,1992,7(3):445. 被引量:1
  • 2Sekido Y,Bader S,Latif F,et al.Molecular analysis of the Von Hippel-Lindsu disease tumor suppressor gene in human lung cancer lines.Onco-gene,1994,9(3):53. 被引量:1
  • 3Hung T,Kishimato Y,Sugio K,et al.Allele-specific chromosome 3p deletion occur at an early stage in the pathogenesis of lung carcinoma .JAMA,1995,273(7):558. 被引量:1
  • 4Noguchi M,Maczawa N,Nakanishi Y,et al.Application of the p^53 gene mutation pattem for differential diagnosis of primary versus metastatic lung cancer.Diagn Mol Pathol,1993,2(1):29. 被引量:1
  • 5Beidler TL.Ultrasensitive staining of nucleic acid with silver.Ann Biochem,1982,126(2):374. 被引量:1
  • 6Knudson AG.Hereditary cancers:Clues to mechanisms of carcinogenesis.Br J Cancer,1989,59(5):661. 被引量:1
  • 7Minna D.Tumor suppressor genes and oncogenes in lung cancer:Potential clinical applications.Advances in Oncology,1996,12(1):3. 被引量:1
  • 8Chiba W,Sawai S,Lkeda S,et al.Detection of loss of heterozygosity by microsatellite probe and DNA content analysis.Can To Kagaku Ryobo,1995,22(Suppl):158. 被引量:1
  • 9Whang-Peng J,Knutsen T,Gazdar A,et al.Non-random structual and numerical chromosome changes in non-small cell lung cancer.Genes Chromosome Cancer,1991,3(3):168. 被引量:1
  • 10Otsuka T,Kahno T,Mori M,et al.Deletion mapping of chromosome 2 in human lung carcinoma.Genes Chromosome Cancer,1996,16(2):113. 被引量:1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部